Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)

Historic Change in Cash for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$5.8 million.

  • Benitec Biopharma's Change in Cash fell 11574.25% to -$5.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $46.9 million, marking a year-over-year decrease of 311.94%. This contributed to the annual value of $46.9 million for FY2025, which is 311.94% down from last year.
  • As of Q2 2025, Benitec Biopharma's Change in Cash stood at -$5.8 million, which was down 11574.25% from $25.3 million recorded in Q1 2025.
  • Benitec Biopharma's Change in Cash's 5-year high stood at $36.8 million during Q2 2024, with a 5-year trough of -$6.2 million in Q1 2024.
  • Over the past 5 years, Benitec Biopharma's median Change in Cash value was -$3.5 million (recorded in 2021), while the average stood at $4.7 million.
  • In the last 5 years, Benitec Biopharma's Change in Cash plummeted by 15872.0% in 2022 and then soared by 100240.49% in 2024.
  • Quarter analysis of 5 years shows Benitec Biopharma's Change in Cash stood at -$3.4 million in 2021, then crashed by 76.46% to -$6.0 million in 2022, then increased by 8.46% to -$5.5 million in 2023, then surged by 290.2% to $10.4 million in 2024, then crashed by 155.45% to -$5.8 million in 2025.
  • Its Change in Cash was -$5.8 million in Q2 2025, compared to $25.3 million in Q1 2025 and $10.4 million in Q4 2024.